Last reviewed · How we verify
NCT05833607
Effects of Targets of Blood Pressure on Cerebral Hemodynamics in Septic Shock
trial in Septic Shock in 40 participants. Status unknown.
30 December 2023
Quick facts
| Lead sponsor | D'Or Institute for Research and Education |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 40 |
| Start date | 7 July 2022 |
| Primary completion | 30 December 2023 |
| Estimated completion | 7 July 2024 |
| Sites | 1 location across Brazil |
Conditions studied
- Septic Shock — all drugs for Septic Shock →
- Cerebral Autoregulation — all drugs for Cerebral Autoregulation →
Sponsor
D'Or Institute for Research and Education
Who can join
18 and older, any sex, with Septic Shock or Cerebral Autoregulation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The sudy objective is to evaluate the cerebral haemodynamic status in different ranges of systemic arterial pressure in patients with septic shock by noninvasive tools, transcranial doppler and intracranial compliance by mechanical sensor (B4C). Patients participating in the study will be submitted to different levels of arterial pressure, titrated with vasopressor and them their cerebral hemodynamic variables will be evaluated,
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Impact of different blood pressure targets on cerebral hemodynamics in septic shock: A prospective pilot study protocol-SEPSIS-BRAIN.
Cury P, Passos RDH, Alves F, Brasil S, et al · · 2024 · cited 2× · PMID 39401208 · DOI 10.1371/journal.pone.0304412
Verify or expand the search:
- PubMed search for NCT05833607
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Septic Shock
Currently open trials in the same condition.
- NCT07179276 — Veno-arterial Carbon Dioxide Partial Pressure Difference (CO2gap) for Early Resuscitation of Septic Shock · NA · recruiting
- NCT07383103 — Hydrocortisone and Fludrocortisone for the Treatment of Septic Shock · Phase 4 · recruiting
- NCT07419802 — OxiCLEAR (Oxiris Cytokines and Endotoxin Adsorption Rate) Study · recruiting
- NCT07264543 — Early Methylene Blue in the Microhemodynamics of Septic Patients · Phase 2, PHASE3 · recruiting
- NCT04855786 — External Drainage of Thoracic Duct Lymph to Reduce Inflammatory Cytokines in Septic Shock Patients · NA · recruiting
Other D'Or Institute for Research and Education trials
Trials by the same sponsor.
- NCT07372144 — Creatine and Cognitive Health in Patients With Early-stage Breast Cancer During and After Chemotherapy Treatment · Phase 3 · not yet recruiting
- NCT07074106 — TIL-Driven De-escalated Chemotherapy in Stage I-II TNBC · Phase 2 · recruiting
- NCT06725537 — Comprehensive Demographics and Clinical Profile of NSCLC Patients · not yet recruiting
- NCT06002841 — Extracellular Vesicles From Mesenchymal Cells in the Treatment of Acute Respiratory Failure · Phase 1, PHASE2 · unknown
- NCT06091384 — Inspiratory Muscle Strength Training in Post-Covid Syndrome · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05833607 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by D'Or Institute for Research and Education
- Last refreshed: 27 April 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05833607.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing